Truvestments Capital LLC acquired a new position in KKR & Co. Inc. (NYSE:KKR – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 310 shares of the asset manager’s stock, valued at approximately $40,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of KKR. Canada Pension Plan Investment Board grew its holdings in KKR & Co. Inc. by 198.6% in the second quarter. Canada Pension Plan Investment Board now owns 3,207,368 shares of the asset manager’s stock worth $337,543,000 after purchasing an additional 2,133,290 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of KKR & Co. Inc. by 64.7% in the second quarter. Bank of New York Mellon Corp now owns 4,036,821 shares of the asset manager’s stock worth $424,835,000 after buying an additional 1,585,447 shares in the last quarter. APG Asset Management N.V. bought a new position in shares of KKR & Co. Inc. in the second quarter worth approximately $154,468,000. Massachusetts Financial Services Co. MA lifted its stake in shares of KKR & Co. Inc. by 6.4% in the second quarter. Massachusetts Financial Services Co. MA now owns 16,684,133 shares of the asset manager’s stock worth $1,755,838,000 after buying an additional 996,871 shares in the last quarter. Finally, Hsbc Holdings PLC lifted its stake in shares of KKR & Co. Inc. by 315.6% in the second quarter. Hsbc Holdings PLC now owns 1,179,728 shares of the asset manager’s stock worth $124,623,000 after buying an additional 895,891 shares in the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.
Wall Street Analyst Weigh In
KKR has been the topic of several analyst reports. Citigroup upped their target price on shares of KKR & Co. Inc. from $157.00 to $171.00 and gave the stock a “buy” rating in a research note on Friday, October 25th. Argus upgraded shares of KKR & Co. Inc. to a “strong-buy” rating in a research note on Thursday, August 1st. Evercore ISI upped their target price on shares of KKR & Co. Inc. from $135.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Hsbc Global Res upgraded shares of KKR & Co. Inc. to a “strong-buy” rating in a research note on Wednesday, September 18th. Finally, Keefe, Bruyette & Woods restated an “outperform” rating and set a $144.00 price objective (up previously from $125.00) on shares of KKR & Co. Inc. in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $154.14.
KKR & Co. Inc. Stock Performance
KKR opened at $160.13 on Thursday. The stock has a market capitalization of $142.23 billion, a price-to-earnings ratio of 48.67, a PEG ratio of 1.26 and a beta of 1.61. The company has a fifty day moving average of $141.61 and a 200 day moving average of $122.59. KKR & Co. Inc. has a fifty-two week low of $68.89 and a fifty-two week high of $162.73. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.07 and a current ratio of 0.07.
KKR & Co. Inc. (NYSE:KKR – Get Free Report) last issued its quarterly earnings data on Thursday, October 24th. The asset manager reported $1.38 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.35. KKR & Co. Inc. had a net margin of 13.21% and a return on equity of 5.77%. The business had revenue of $4.79 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same period last year, the company posted $0.73 EPS. As a group, sell-side analysts forecast that KKR & Co. Inc. will post 4.16 earnings per share for the current fiscal year.
KKR & Co. Inc. Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th were paid a $0.175 dividend. The ex-dividend date of this dividend was Monday, November 4th. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.44%. KKR & Co. Inc.’s payout ratio is currently 21.28%.
Insiders Place Their Bets
In other news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of the stock in a transaction dated Wednesday, September 11th. The stock was purchased at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the acquisition, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. The trade was a 14.29 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This trade represents a 18.67 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 39.34% of the company’s stock.
KKR & Co. Inc. Profile
KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- Why Invest in 5G? How to Invest in 5G Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Top Biotech Stocks: Exploring Innovation Opportunities
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What does consumer price index measure?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.